213 related articles for article (PubMed ID: 31256145)
1. Predicting the Risk of Huntington's Disease with Multiple Longitudinal Biomarkers.
Li F; Li K; Li C; Luo S;
J Huntingtons Dis; 2019; 8(3):323-332. PubMed ID: 31256145
[TBL] [Abstract][Full Text] [Related]
2. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Paulsen JS; Long JD; Ross CA; Harrington DL; Erwin CJ; Williams JK; Westervelt HJ; Johnson HJ; Aylward EH; Zhang Y; Bockholt HJ; Barker RA;
Lancet Neurol; 2014 Dec; 13(12):1193-201. PubMed ID: 25453459
[TBL] [Abstract][Full Text] [Related]
3. Validation of a prognostic index for Huntington's disease.
Long JD; Langbehn DR; Tabrizi SJ; Landwehrmeyer BG; Paulsen JS; Warner J; Sampaio C
Mov Disord; 2017 Feb; 32(2):256-263. PubMed ID: 27892614
[TBL] [Abstract][Full Text] [Related]
4. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
Long JD; Paulsen JS;
Mov Disord; 2015 Oct; 30(12):1664-72. PubMed ID: 26340420
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and Motor Norms for Huntington's Disease.
Mills JA; Long JD; Mohan A; Ware JJ; Sampaio C
Arch Clin Neuropsychol; 2020 Aug; 35(6):671-682. PubMed ID: 32407458
[TBL] [Abstract][Full Text] [Related]
6. Prodromal Cognitive Changes as a Prognostic Indicator of Forthcoming Huntington's Disease Severity: A Retrospective Longitudinal Study.
Migliore S; Bianco SD; Scocchia M; Maffi S; Busi LC; Ceccarelli C; Curcio G; Mazza T; Squitieri F
Mov Disord Clin Pract; 2024 Apr; 11(4):363-372. PubMed ID: 38264920
[TBL] [Abstract][Full Text] [Related]
7. Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington's disease.
Long JD; Mills JA
BMC Med Res Methodol; 2018 Nov; 18(1):138. PubMed ID: 30445915
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
Lowe AJ; Sjödin S; Rodrigues FB; Byrne LM; Blennow K; Tortelli R; Zetterberg H; Wild EJ
PLoS One; 2020; 15(8):e0233820. PubMed ID: 32804976
[TBL] [Abstract][Full Text] [Related]
9. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
10. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Prediction of Motor Diagnosis in Huntington's Disease Using a Joint Modeling Approach.
Li K; Furr-Stimming E; Paulsen JS; Luo S;
J Huntingtons Dis; 2017; 6(2):127-137. PubMed ID: 28582868
[TBL] [Abstract][Full Text] [Related]
13. Understanding HD Psychosis: An Analysis from the ENROLL-HD Database.
Jaini A; Yomtoob J; Yeh C; Bega D
Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():16. PubMed ID: 32775030
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
[TBL] [Abstract][Full Text] [Related]
15. Assessing Decline: Visualising Progression in Huntington's Disease using a Clinical Dashboard with Enroll-HD Data.
Walker T; Ghosh B; Kipps C
J Huntingtons Dis; 2017; 6(2):139-147. PubMed ID: 28550266
[TBL] [Abstract][Full Text] [Related]
16. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
Long JD; Mills JA; Leavitt BR; Durr A; Roos RA; Stout JC; Reilmann R; Landwehrmeyer B; Gregory S; Scahill RI; Langbehn DR; Tabrizi SJ;
JAMA Neurol; 2017 Nov; 74(11):1352-1360. PubMed ID: 28975278
[TBL] [Abstract][Full Text] [Related]
17. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
[TBL] [Abstract][Full Text] [Related]
18. A Machine-Learning Derived Huntington's Disease Progression Model: Insights for Clinical Trial Design.
Mohan A; Sun Z; Ghosh S; Li Y; Sathe S; Hu J; Sampaio C
Mov Disord; 2022 Mar; 37(3):553-562. PubMed ID: 34870344
[TBL] [Abstract][Full Text] [Related]
19. Resting-state fMRI reveals potential neural correlates of impaired cognition in Huntington's disease.
Liu W; Yang J; Chen K; Luo C; Burgunder J; Gong Q; Shang H
Parkinsonism Relat Disord; 2016 Jun; 27():41-6. PubMed ID: 27117563
[TBL] [Abstract][Full Text] [Related]
20. Rate of functional decline in Huntington's disease. Huntington Study Group.
Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
